Quick Answer
A high Streptococcus spp. result on the GI-MAP usually indicates an opportunistic bacterial overgrowth rather than an infection. Common contributors include low stomach acid, PPI use, SIBO, constipation, and reduced digestion. Many people have no symptoms. The result is most useful when interpreted alongside H. pylori, Enterococcus, and digestion markers.
| Result | What it means |
|---|---|
| Within range | No Streptococcus overgrowth detected |
| High | Opportunistic bacterial overgrowth — review potential drivers (low stomach acid, PPIs, SIBO, constipation, reduced digestion) and read alongside related markers |
If your GI-MAP shows Streptococcus spp. flagged high, the test detected more Streptococcus DNA in your stool than its reference range allows. This is best read as a clue about your gut environment, not as evidence of an infection on its own.
What is Streptococcus spp.?
Streptococcus is a genus of Gram-positive, lactic-acid–producing bacteria in the Firmicutes phylum. The abbreviation "spp." means "species" (plural) — the GI-MAP reports the whole genus as a group rather than naming a single species. Many Streptococcus species are non-pathogenic and live as normal (commensal) flora on the skin and in the mouth, throat, upper respiratory tract, urogenital tract, and gastrointestinal tract.
Where Streptococcus spp. sits on the GI-MAP
The GI-MAP lists Streptococcus spp. among the Opportunistic Bacteria reported as Dysbiotic / Overgrowth. "Opportunistic" means these microbes are usually harmless and are considered normal in stool, but can contribute to symptoms in some people — particularly at high levels or in those who are immunocompromised. The GI-MAP quantifies them using qPCR, which measures the amount of bacterial DNA present, so a "high" flag means the measured level is above the lab's reference range.
How research links Streptococcus spp. to gut inflammation
Some studies report a relative increase in Streptococcus spp. in people with inflammatory bowel disease (IBD) compared with controls, and Streptococcus bovis/gallolyticus has been associated with IBD and colorectal cancer in older literature. Other studies report the opposite — reduced Streptococci in IBD — so the relationship is not settled. These are associations, not proof of cause, and they describe specific species or clinical groups, not every elevated GI-MAP result. If you have IBD, a family history of colorectal cancer, or persistent GI symptoms, this is worth discussing with the practitioner who ordered your test.
How is high Streptococcus spp. typically addressed?
A single high marker is a starting point, not a diagnosis, and the GI-MAP itself doesn't prescribe treatment. Because elevated opportunistic bacteria usually reflect an overgrowth-friendly environment rather than an infection, practitioners generally look for and address the underlying driver rather than targeting Streptococcus directly. Areas they commonly review include:
- Stomach acid status — low stomach acid (hypochlorhydria) is the most-cited contributor.
- Acid-suppressing medications — reviewing PPI or other acid-suppressant use with the prescriber.
- Digestion — supporting digestive capacity (e.g. enzyme output) where it's reduced.
- Constipation and transit time — slow clearance gives bacteria more time to multiply.
- The wider GI-MAP — interpreting Streptococcus alongside H. pylori, Enterococcus, commensals, and the digestion/inflammation markers, plus actual symptoms.
- Retesting — because the GI-MAP is quantitative, a follow-up test confirms whether levels actually moved.
This is not prescriptive guidance. Any specific protocol should be decided with the practitioner who ordered your test, especially if you are pregnant, immunocompromised, or over 65.
Symptoms that can accompany high Streptococcus spp.
Many people with a high result have no symptoms. When symptoms do occur, they are gastrointestinal rather than systemic, and may include loose stools or diarrhea, abdominal pain or cramping, bloating, and constipation.
Opportunistic bacteria rarely cause invasive illness in otherwise healthy people. However, if you are immunocompromised, pregnant, or over 65, or if you have a fever or feel systemically unwell, contact your healthcare provider rather than relying on a stool marker alone.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →Frequently Asked Questions
What does "spp." mean in Streptococcus spp.?
Is Streptococcus normal in stool?
Is a high Streptococcus spp. on the GI-MAP dangerous?
Is Streptococcus spp. the same as Group B Streptococcus (GBS)?
What causes high Streptococcus spp. in stool?
What are the symptoms of high Streptococcus spp.?
Can high Streptococcus spp. mean low stomach acid?
What does gamma-hemolytic Streptococcus in stool mean?
Which Streptococcus species does the GI-MAP detect?
How do you lower high Streptococcus spp.?
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.
-
Heidarian F, Noormohammadi Z, Asadzadeh Aghdaei H, Alebouyeh M. Relative Abundance of Streptococcus spp. and its Association with Disease Activity in Inflammatory Bowel Disease Patients Compared with Controls.
-
Ecology and pathogenicity of gastrointestinal Streptococcus bovis
-
Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission
-
Prevalence of colorectal cancer associated with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease patients
-
Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease